MUC16 and cancer: Recent studies highlighted the possible mechanisms by which MSLN could play an active role in cancer progression; it was shown to interact with MUC16 [12], and to activate the p38 pathway, leading to the selective induction of matrix metalloproteinase (MMP)-7 [13].